Venture
Affiliations
New York University
Technologies
Therapeutic
Indication
Oncology
Personalized Medicine
Website
www.tezcat.coTEZCAT is developing a biologics-based therapeutic approach to treat mutant Ras cancers, such as colorectal cancer.
TEZCAT team:
CEO – Alex Efron
CSO – Craig Ramirez, Ph.D.
Ops. Mgr – Andy Hauser, Ph.D.